However, no difference seen for care guided by C-reactive protein measurement

Increased odds of LV hypertrophy, high relative wall thickness, LV diastolic dysfunction, high LV filling pressure

Higher increase in rates over time seen for Black and Asian patients versus White patients and for Medicaid, Medicare patients

Findings for primary tumors of 0.8 to 1.0 mm versus those <0.8 mm

Highest percentage of patients with HBsAg loss after end of treatment for those receiving xalnesiran + immunomodulator

Two-year cumulative rate of invasive ipsilateral breast cancer 5.9 and 4.2 percent for guideline-concordant care, active monitoring

SSRI-exposed children did not have increased risk of functional nausea and vomiting or functional abdominal pain disorders

Hazard ratio up for incident venous thromboembolism in association with higher levels of fine particulate matter, oxides of nitrogen, nitrogen dioxide

Exposure to pressure ulcers linked to impaired motor recovery one year after spinal cord injury

Omission noninferior to sentinel-lymph-node biopsy for clinically node-negative early-stage invasive breast cancer